Ken Griffin Cocrystal Pharma, Inc. Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.27 - $3.6 $21,577 - $287,704	79,918 New	79,918 $23,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.25 $1,415 - $1,751	-1,401 Reduced 1.28%	108,335 $114,000
Q2 2021 Aug 16, 2021	BUY	$1.08 - $2.14 $118,514 - $234,835	109,736 New	109,736 $137,000
Q2 2020 Aug 14, 2020	SELL	$0.7 - $1.58 $20,213 - $45,624	-28,876 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.48 - $2.19 $3,129 - $14,276	-6,519 Reduced 18.42%	28,876 $21,000
Q4 2019 Feb 14, 2020	BUY	$0.39 - $2.05 $7,887 - $41,461	20,225 Added 133.32%	35,395 $18,000
Q2 2019 Aug 14, 2019	BUY	$2.06 - $2.75 $737 - $984	358 Added 2.42%	15,170 $36,000
Q1 2019 May 15, 2019	BUY	$2.65 - $4.14 $39,251 - $61,321	14,812 New	14,812 $0

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $19.1M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.